BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10068933)

  • 1. [An unusual hemorrhagic variant of Stevens-Johnson syndrome in an HIV-infected patient].
    Schmid MH; Elsner P
    Hautarzt; 1999 Jan; 50(1):52-5. PubMed ID: 10068933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole-induced Stevens-Johnson syndrome: a case report.
    Langlois MR; Derk F; Belczyk R; Zgonis T
    J Am Podiatr Med Assoc; 2010; 100(4):299-303. PubMed ID: 20660883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole.
    Douglas R; Spelman D; Czarny D; O'Hehir RE
    Clin Infect Dis; 1997 Dec; 25(6):1480. PubMed ID: 9431406
    [No Abstract]   [Full Text] [Related]  

  • 4. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
    Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
    Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
    [No Abstract]   [Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole-induced Steven Johnson syndrome in an HIV-infected patient.
    Taqi SA; Zaki SA; Nilofer AR; Sami LB
    Indian J Pharmacol; 2012; 44(4):533-5. PubMed ID: 23087524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxic epidermal necrolysis (Lyell syndrome), a lifethreatening emergency of introgenic origin].
    Piérard GE; Jennes S; Piérard-Franchimont C
    Rev Med Liege; 2016 Oct; 71(10):435-439. PubMed ID: 28383851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cotrimoxazole induced dermatitis and curative treatment of AIDS pneumocystosis].
    Caumes E
    Rev Mal Respir; 1996; 13(2):101-6. PubMed ID: 8711227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous artifactual disease represented as recurrent toxic epidermal necrolysis.
    Gowring LE; Johnson R; Hivnor CM; Henning JS
    Cutis; 2016 Sep; 98(3):E6-E7. PubMed ID: 27814420
    [No Abstract]   [Full Text] [Related]  

  • 10. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.
    Dharamsi FM; Michener MD; Dharamsi JW
    J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe adverse cutaneous reactions to drugs.
    Roujeau JC; Stern RS
    N Engl J Med; 1994 Nov; 331(19):1272-85. PubMed ID: 7794310
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection.
    Porteous DM; Berger TG
    Arch Dermatol; 1991 May; 127(5):740-1. PubMed ID: 1827245
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome after erythromycin therapy while deployed at sea.
    Williams DA
    Mil Med; 2000 Aug; 165(8):636-7. PubMed ID: 10957862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patch testing in an unusual case of toxic epidermal necrolysis.
    Klein CE; Trautmann A; Zillikens D; Bröcker EB
    Contact Dermatitis; 1995 Dec; 33(6):448-9. PubMed ID: 8706422
    [No Abstract]   [Full Text] [Related]  

  • 16. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with AIDS.
    Belfort R; de Smet M; Whitcup SM; Pavesio C; Lottenberg C; Rubin B; Lopez JS; Nussenblatt R
    Cornea; 1991 Nov; 10(6):536-8. PubMed ID: 1782783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Wildermuth A
    JAAPA; 2020 Aug; 33(8):48-49. PubMed ID: 32740115
    [No Abstract]   [Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme.
    Roujeau JC
    J Dermatol; 1997 Nov; 24(11):726-9. PubMed ID: 9433029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole.
    Rijal JP; Pompa T; Giri S; Bhatt VR
    BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 25008332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.